US & EU Medical Regulations
FDA 21 CFR Part 11 – Overview
FDA 21 CFR Part 11 is a regulation that establishes guidelines for electronic records and electronic signatures, ensuring they hold the same legal standing as paper-based records. It applies to medical device manufacturers, pharmaceutical companies, and other regulated industries that manage electronic data. Compliance with this regulation enhances data security, traceability, and audit readiness. By implementing Part 11-compliant software solutions, organizations can improve operational efficiency, maintain regulatory compliance, and ensure data integrity while reducing risks associated with non-compliance.
Benefits of FDA 21 CFR Part 11 Compliance
21 CFR Part 820 – Quality System Regulation for Medical Devices
21 CFR Part 820, issued by the FDA, establishes the Quality System Regulation (QSR) for medical device manufacturers in the U.S. It ensures that all devices meet safety and quality standards throughout their development, production, and distribution. Compliance is mandatory for all manufacturers selling in the U.S., and non-compliance can result in warning letters, regulatory action, and reputational damage.
Key Components of 21 CFR Part 820
- Manufacturers must implement a robust quality management system (QMS) to ensure regulatory compliance.
- Strict design documentation, change control processes, and traceability measures are required.
PAN Card & Address Proof
Employee Details (if applicable)
- Proper procedures for device manufacturing, testing, and corrective actions must be in place.
- Suppliers must comply with regulatory standards, and purchasing processes must be documented.
- Finished devices must be uniquely identified to track and resolve potential safety issues.
- Manufacturers must have corrective and preventive action (CAPA) procedures to handle defects and prevent reoccurrences.
- Ensures accurate labelling, safe packaging, and proper handling of medical devices.
- Detailed records, including complaint files, must be maintained for FDA review.
Benefits of Compliance
Adopting a compliant quality management system enhances product safety, minimizes risks, and builds market trust. A well-structured QMS simplifies compliance, reduces manufacturing errors, and ensures continuous improvement in quality control processes.
IEC 62304 – Ensuring Safe Medical Device Software
In the early 2000s, the need for a structured approach to medical device software safety became evident. As software became a critical component of medical devices—from monitoring systems to diagnostic and therapeutic equipment—errors in software posed serious risks.
A well-known case highlighting this issue is the Therac-25 Radiation Therapy Machine. A flaw in its control software led to a critical race condition, causing patients to receive dangerously high radiation doses. This resulted in burns, tissue damage, and organ dysfunction. While it’s unclear if compliance with IEC 62304 could have entirely prevented this tragedy, the standard aims to minimize software-related risks in medical devices.
The Importance of IEC 62304 Compliance
IEC 62304 establishes a framework for software lifecycle processes, ensuring systematic risk management and comprehensive software testing. It provides guidance on:
Software risk management
Systematic software testing
Configuration and problem resolution management
Key Process in IEC 62304
Scope & Normative References
General Requirements
Software Development Process
Software Maintenance Process
Software Risk Management Process
Software Configuration & Problem Resolution
EU MDR 2017/745
The European Union’s Medical Device Regulation (EU) 2017/745 (MDR) was enforced on May 25, 2021, replacing the previous Medical Device Directive (MDD). It establishes stricter requirements for medical device manufacturers worldwide, including those outside the EU, ensuring product safety, quality, and traceability. The MDR introduces key changes, such as expanded scope, enhanced clinical evaluation, stricter documentation, high-risk device scrutiny, mandatory Unique Device Identification (UDI), a centralized EUDAMED database, and post-market surveillance. Compliance with MDR is crucial for manufacturers aiming to enter or continue operating in the European market.
Key Innovations and Requirements in Regulation (EU) 2017/745
Expanded Scope
Stricter Documentation & Clinical Evaluation
High-Risk Device Scrutiny
UDI System & EUDAMED
Post-Market Surveillance
Regulatory Compliance Officer
AccorpMed streamlines medical compliance with expert licensing and certification solutions. Trusted by 100+ healthcare businesses, we ensure hassle-free approvals for land, product, labor, and distribution licenses.
Contact Information
support@accorpmed.com
+91 99682 97717
909, ITL Twin Tower, B-9, Netaji Subhash Place, Pitampura, Delhi-110034 (INDIA)
2025-26 © accorpmed.com | All Rights Reserved